Emerson Collective Cancer Research Fund

Funding Agency:
Emerson Collective

Emerson Collective deploys a wide range of tools—from impact investing to philanthropy to advocacy—in pursuit of a more equal and just America.  We focus on creating systemic change in education, immigration, climate, and cancer research and treatment.

Advances in cancer research—including the advent of genetic sequencing, immunology, and improvements in disease detection—have combined to make this a pivotal moment of potential progress in cancer biology research and treatment.  Thanks to these developments, we see new tangible steps that can be taken to potentially reduce the burden of cancer in the lives of patients, their families, and caregivers.

Emerson Health partners with leading, cutting-edge researchers and innovative entrepreneurs to help transform groundbreaking scientific discoveries into potentially groundbreaking treatments for patients with significant, unmet needs.

The Emerson Collective Cancer Research Fund is requesting individual or team proposals for research projects related to the following topic areas:

•  Engineering allogeneic cells with new properties to:

  1. prevent their recognition by the host immune system;
  2. promote their persistence in the host;
  3. defeat suppressive mechanisms of the tumor microenvironment;
  4. synergize with host innate and adaptive immune systems; and/or,
  5. allow gating or other regulation of their functions temporally or geographically to improve potency or reduce toxicity.  

•  Validating new target antigens for cell therapy in cancer

•  Targeted intracellular gene or protein delivery mechanisms

•  Enabling early cancer detection

Deadline: June 16, 2021

Agency Website

Eligibility Requirements

This RFA is open to all faculty and trainees sponsored by faculty undertaking research relevant to cancer at eligible research institutions.  Awards range from one to two years, and must include both direct and indirect costs in a proposed budget.  Additional questions regarding eligibility should be emailed to healthgrants@emersoncollective.com

Funding Type



Medical Fellow/Resident


Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 16, 2021